RxEye experienced 'exceptional' growth in 2015
Inhibiting a protein receptor topically may yield better cosmetic and functional outcomes
Now 13 Blue Cross Blue Shield licensees cover treatment
Whether it’s repealed depends on next president
Head of global policy and government affairs at Siemens Healthcare discusses the biggest trends in the industry
“Patient-physician email communication will grow in the future”
State and regulatory clearance expected in a few months
Another step toward standardization
£10 million investment made today
State needs to expand Medicaid or develop alternative system
With significant cost and space savings, will this become a trend?
New company expected to earn $1.1 billion in annual sales
Could be useful in distinguishing from PTSD
Another study finds hallucinogenic 'trip' may help patients cope with life-threatening diagnoses
Using hydrogen atoms to produce high-definition, color-coded T1 values
After 10 years of clinical trials, focused ultrasound is FDA approved for prostate
Progress is being made
Seven out of 10 DBS-eligible patients may need MR
Increasingly, studies are supporting the use of brachytherapy for certain indications
Researchers optimistic about combining ablation, drug and immunotherapy
May create pathway to better epilepsy treatments
Rates of uninsured declined by 7 percent
Could become the standard if reimbursement's there
Could be a game-changer for fluoro and CT too
First system to acquire 3-D natural weight-bearing images
World's first long-length DR detector and FDR Visionary Suite
How clinically significant are multicentric cancers?
But it may not apply to all bilingual people
May reduce radiation dose and cost associated with current X-ray devices
Use of CT in ED more than tripled in 20 years
From the December issue of HCB News magazine
'An extremely tiny stethoscope you can swallow'
A more economical option
First ultrasound solution offered on a subscription basis
One of six acquisitions in as many months
Projected $11.1 million in savings
Especially useful for treating brain cancer and aneurysms
Shown to be 96 percent accurate
Only imaging device approved to diagnose early liver disease
Bringing “smart hospitals” to life
Holds promise in treating brain tumors, Parkinson’s, Alzheimer’s and more
U.S. closer to a domestic commercial supply of the SPECT workhorse isotope
Over two-thirds of U.S. adults are overweight or obese
A 'breakthrough' in merging neurosurgical robotics and intraoperative imaging
Active surveillance surprisingly inexpensive
New drug candidates are showing promise
He sees “great untapped potential” in IMRIS technology
“Ugh, having an MRI is like being inside a pissed-off fax machine!”
From the November issue of HCB News magazine
